Covid-19, the reality bites. All the talk, now it is happening. At the largest hospital in the land, all the docs have been told to report for general duties. Read this: https://multiple-sclerosis-research.org/2020/03/covid19-reality-bites/ It is really hitting home.
Thee is a new global survey from colleagues in Sydney that you may want to take part in. It is patient-centred. The aim of the survey is to find out what effects of treatment and care (also known as outcomes) are important and relevant to patients with suspected or confirmed COVID-19, family members, community members and health professionals. http://tiny.cc/aas7lz
I am a participant in this debate: Should ocrelizumab and cladribine be treated in the same way as alemtuzumab in terms of risk of COVID-19? in an hour. Will report if it doesn’t descend into polarised positions. Knowing the participants – well, one of them – it may. Opinions remain strong, virus or otherwise.
If you like wasting time and procrastinating as mu7ch as I do then build a paperclip empire here: https://www.decisionproblem.com/paperclips/index2.html
Am off to coffee and prep for the debate!
Take care and don’t get the bloody virus right now 😉
Browse categories and add by clicking on them
You can remove current categories below by clicking the ‘x’.